Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2007 (2007), Article ID 81654, 7 pages
http://dx.doi.org/10.1155/2007/81654
Research Article

Inhibition of Protein Farnesylation Arrests Adipogenesis and Affects PPARγ Expression and Activation in Differentiating Mesenchymal Stem Cells

1Lady Davis, Institute for Medical Research, Montreal, Quebec, QC H3T 1E2, Canada
2Nepean Clinical School, University of Sydney, Penrith, NSW 2750, Australia

Received 5 July 2007; Revised 16 August 2007; Accepted 1 October 2007

Academic Editor: Jeffrey M. Gimble

Copyright © 2007 Daniel Rivas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Goltzman, “Discoveries, drugs and skeletal disorders,” Nature Reviews Drug Discovery, vol. 1, no. 10, pp. 784–796, 2002. View at Publisher · View at Google Scholar
  2. L. G. Raisz and E. Seeman, “Causes of age-related bone loss and bone fragility: an alternative view,” Journal of Bone and Mineral Research, vol. 16, no. 11, pp. 1948–1952, 2001. View at Publisher · View at Google Scholar
  3. G. Duque and B. Troen, “Osteoporosis,” in Hazzard's Textbook in Geriatric Medicine, W. R. Hazzard et al., Ed., McGraw-Hill, New York, NY, USA, 6 edition, 2007, chapter 75. View at Google Scholar
  4. G. K. Chan and G. Duque, “Age-related bone loss: old bone, new facts,” Gerontology, vol. 48, no. 2, pp. 62–71, 2002. View at Publisher · View at Google Scholar
  5. B. Lecka-Czernik, E. J. Moerman, D. F. Grant, J. M. Lehmann, S. C. Manolagas, and R. L. Jilka, “Divergent effects of selective peroxisome proliferator-activated receptor-γ2 ligands on adipocyte versus osteoblast differentiation,” Endocrinology, vol. 143, no. 6, pp. 2376–2384, 2002. View at Publisher · View at Google Scholar
  6. J. L. Kirkland, T. Tchkonia, T. Pirtskhalava, J. Han, and I. Karagiannides, “Adipogenesis and aging: does aging make fat go MAD?” Experimental Gerontology, vol. 37, no. 6, pp. 757–767, 2002. View at Publisher · View at Google Scholar
  7. J. L. Kirkland and D. E. Dobson, “Preadipocyte function and aging: links between age-related changes in cell dynamics and altered fat tissue function,” Journal of the American Geriatrics Society, vol. 45, no. 8, pp. 959–967, 1997. View at Google Scholar
  8. L. Pei and P. Tontonoz, “Fat's loss is bone's gain,” Journal of Clinical Investigation, vol. 113, no. 6, pp. 805–806, 2004. View at Publisher · View at Google Scholar
  9. T. Akune, S. Ohba, S. Kamekura et al., “PPAR?insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors,” Journal of Clinical Investigation, vol. 113, no. 6, pp. 846–855, 2004. View at Publisher · View at Google Scholar
  10. T. Tchkonia, Y. D. Tchoukalova, N. Giorgadze et al., “Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots,” American Journal of Physiology. Endocrinology and Metabolism, vol. 288, no. 1, pp. E267–E277, 2005. View at Google Scholar
  11. D. J. Klemm, J. W. Leitner, P. Watson et al., “Insulin-induced adipocyte differentiation: activation of CREB rescues adipogenesis from the arrest caused by inhibition of prenylation,” Journal of Biological Chemistry, vol. 276, no. 30, pp. 28430–28435, 2001. View at Publisher · View at Google Scholar
  12. R. D. Moir and T. P. Spann, “The structure and function of nuclear lamins: implications for disease,” Cellular and Molecular Life Sciences, vol. 58, no. 12-13, pp. 1748–1757, 2001. View at Publisher · View at Google Scholar
  13. R. L. Boguslavsky, C. L. Stewart, and H. J. Worman, “Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy,” Human Molecular Genetics, vol. 15, no. 4, pp. 653–663, 2006. View at Publisher · View at Google Scholar
  14. T. Sullivan, D. Escalante-Alcalde, H. Bhatt et al., “Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy,” Journal of Cell Biology, vol. 147, no. 5, pp. 913–920, 1999. View at Publisher · View at Google Scholar
  15. C. Capanni, E. Mattioli, M. Columbaro et al., “Altered pre-lamin a processing is a common mechanism leading to lipodystrophy,” Human Molecular Genetics, vol. 14, no. 11, pp. 1489–1502, 2005. View at Publisher · View at Google Scholar
  16. G. Duque and D. Rivas, “Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells,” Journal of Bone and Mineral Research, vol. 22, no. 10, pp. 1603–1611, 2007. View at Publisher · View at Google Scholar
  17. B. C. Capell, M. R. Erdos, J. P. Madigan et al., “Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 36, pp. 12879–12884, 2005. View at Publisher · View at Google Scholar
  18. G. Duque, K. E. Abdaimi, M. Macoritto, M. M. Miller, and R. Kremer, “Estrogens (E2) regulate expression and response of 1,25-dihydroxyvitamin D3 receptors in bone cells: changes with aging and hormone deprivation,” Biochemical and Biophysical Research Communications, vol. 299, no. 3, pp. 446–454, 2002. View at Publisher · View at Google Scholar
  19. G. Duque, M. Macoritto, and R. Kremer, “Vitamin D treatment of senescence accelerated mice (SAM-P/6) induces several regulators of stromal cell plasticity,” Biogerontology, vol. 5, no. 6, pp. 421–429, 2004. View at Publisher · View at Google Scholar
  20. M. E. Nuttall and J. M. Gimble, “Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis?” Bone, vol. 27, no. 2, pp. 177–184, 2000. View at Publisher · View at Google Scholar
  21. J. E. Aubin and J. T. Triffitt, “Mesenchymal stem cells and osteoblast differentiation,” in Principles of Bone Biology, pp. 59–81, Academic Press, Boston, Mass, USA, 2nd edition, 2002. View at Google Scholar
  22. S.-C. Hung, C.-F. Chang, H.-L. Ma, T.-H. Chen, and L. Low-Tone Ho, “Gene expression profiles of early adipogenesis in human mesenchymal stem cells,” Gene, vol. 340, no. 1, pp. 141–150, 2004. View at Publisher · View at Google Scholar
  23. G. Duque, M. Macoritto, and R. Kremer, “1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARγ2),” Experimental Gerontology, vol. 39, no. 3, pp. 333–338, 2004. View at Publisher · View at Google Scholar
  24. A. A. Ali, R. S. Weinstein, S. A. Stewart, A. M. Parfitt, S. C. Manolagas, and R. L. Jilka, “Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation,” Endocrinology, vol. 146, no. 3, pp. 1226–1235, 2005. View at Publisher · View at Google Scholar
  25. S. G. Young, L. G. Fong, and S. Michaelis, “Prelamin A, Zmpste24, misshapen cell nuclei, and progeria-new evidence suggesting that protein farnesylation could be important for disease pathogenesis,” Journal of Lipid Research, vol. 46, no. 12, pp. 2531–2558, 2005. View at Publisher · View at Google Scholar
  26. Y. Liu, A. Rusinol, M. Sinensky, Y. Wang, and Y. Zou, “DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A,” Journal of Cell Science, vol. 119, no. 22, pp. 4644–4649, 2006. View at Publisher · View at Google Scholar
  27. C. J. Lelliott, L. Logie, C. P. Sewter et al., “Lamin expression in human adipose cells in relation to anatomical site and differentiation state,” Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 2, pp. 728–734, 2002. View at Publisher · View at Google Scholar
  28. J. P. DeLany, Z. E. Floyd, S. Zvonic et al., “Proteomic analysis of primary cultures of human adipose-derived stem cells,” Molecular & Cellular Proteomics, vol. 4, no. 6, pp. 731–740, 2005. View at Publisher · View at Google Scholar
  29. A. A. Adjei, J. N. Davis, C. Erlichman, P. A. Svingen, and S. H. Kaufmann, “Comparison of potential markers of farnesyltransferase inhibition,” Clinical Cancer Research, vol. 6, no. 6, pp. 2318–2325, 2000. View at Google Scholar
  30. M. Caron, M. Auclair, H. Sterlingot, M. Kornprobst, and J. Capeau, “Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation,” AIDS, vol. 17, no. 17, pp. 2437–2444, 2003. View at Google Scholar